Andy
Retired committee member
This project is one of several that have been discussed in this thread, The Netherlands - €28.5 million ME/CFS research program - funding awards announced April 2023
I thought it was worth having its own thread primarily due to the sub-projects that are also attached to it.
Project overview.
The Netherlands ME/CFS Cohort and Biobank (NMCB) consortium is a national collaboration of research institutes, patient organisations and clinical centres. The consortium focuses on biomedical research on ME/CFS.
One of the activities of the consortium is the establishment of a comprehensive patient cohort and biobank. In this regard, attention is given to the inclusion of severely ill patients and the application of international diagnostic standards. The biobank collects medical patient data and patient material for scientific research and the cohort forms a patient registry for conducting clinical studies.
Building on this infrastructure, and in close cooperation with patient organisations, researchers within this consortium will conduct studies aimed at gaining more insight into the underlying mechanism of the onset of ME/CFS. The emphasis is on developing new methods for treatment and diagnosis.
The consortium will enter an eight-year collaboration with the ambition to develop a sound understanding of the mechanisms causing ME/CFS and to see this knowledge translated into better treatments and diagnosis.
https://projecten.zonmw.nl/en/project/netherlands-mecfs-cohort-and-biobank-nmcb-consortium
I thought it was worth having its own thread primarily due to the sub-projects that are also attached to it.
Project overview.
The Netherlands ME/CFS Cohort and Biobank (NMCB) consortium is a national collaboration of research institutes, patient organisations and clinical centres. The consortium focuses on biomedical research on ME/CFS.
One of the activities of the consortium is the establishment of a comprehensive patient cohort and biobank. In this regard, attention is given to the inclusion of severely ill patients and the application of international diagnostic standards. The biobank collects medical patient data and patient material for scientific research and the cohort forms a patient registry for conducting clinical studies.
Building on this infrastructure, and in close cooperation with patient organisations, researchers within this consortium will conduct studies aimed at gaining more insight into the underlying mechanism of the onset of ME/CFS. The emphasis is on developing new methods for treatment and diagnosis.
The consortium will enter an eight-year collaboration with the ambition to develop a sound understanding of the mechanisms causing ME/CFS and to see this knowledge translated into better treatments and diagnosis.
https://projecten.zonmw.nl/en/project/netherlands-mecfs-cohort-and-biobank-nmcb-consortium